Estelamari Rodriguez, MD, MPH

University of Miami Health System

Latest Videos

Optimizing ROS1 inhibitor therapy in NSCLC with insights from Dr. Estelamari Rodriguez and colleagues for cancer research and targeted lung cancer treatment.

Videos & Podcasts

11/15/2025

Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPHRohit Gosain, MDRahul Gosain, MD, MBA

Innovative oncology discussion featuring medical experts sharing insights on cancer treatment strategies at OncUpdates conference.

ASCO 2025

06/16/2025

Ep. 3: How to Choose the Best First-Line Therapy for Patients With EGFR-Mutated NSCLC

Susan Scott, MDEstelamari Rodriguez, MD, MPHHelena Yu, MD

Doctor and patient discussion about cancer treatment at OncUpdates conference, emphasizing oncology care and medical research.

ASCO 2025

06/16/2025

EP. 1: Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Estelamari Rodriguez, MD, MPHHelena Yu, MDJoshua Sabari, MD

Mariposa: Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC - Oncology research featuring leading doctors discussing advanced lung cancer treatment options and targeted therapies.

ASCO 2025

06/15/2025

MARIPOSA: Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC

Estelamari Rodriguez, MD, MPHHelena Yu, MDJoshua Sabari, MDSusan Scott, MDRahul Gosain, MD, MBARohit Gosain, MD